P

Inventor

MEZLER MARIO

DE24 patents
⚠️ This page may combine multiple inventors who share the name “MEZLER MARIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABBVIE DEUTSCHLAND

6 patents
US9238619B2Jan 19, 2016

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

ABBVIE DEUTSCHLAND0 citations52
US9096619B2Aug 4, 2015

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

ABBVIE DEUTSCHLAND1 citations52
US9067871B2Jun 30, 2015

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

ABBVIE DEUTSCHLAND0 citations52
US10040852B2Aug 7, 2018

Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof

ABBVIE DEUTSCHLAND0 citations51
US9255146B2Feb 9, 2016

Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof

ABBVIE DEUTSCHLAND0 citations51
US8957089B2Feb 17, 2015

Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy

ABBVIE DEUTSCHLAND1 citations51

TURNER SEAN COLM

3 patents
US8440694B2May 14, 2013

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor

TURNER SEAN COLM12 citations83
US8242102B2Aug 14, 2012

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

TURNER SEAN COLM2 citations60
US8293913B2Oct 23, 2012

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor

TURNER SEAN COLM0 citations50

AMBERG WILHELM

3 patents
US8420670B2Apr 16, 2013

4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy

AMBERG WILHELM17 citations83
US8563617B2Oct 22, 2013

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

AMBERG WILHELM13 citations82
US9309200B2Apr 12, 2016

Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy

AMBERG WILHELM0 citations41

BRAJE WILFRIED

2 patents
US8664214B2Mar 4, 2014

Small molecule potentiators of metabotropic glutamate receptors I

BRAJE WILFRIED5 citations71
US8314120B2Nov 20, 2012

Small molecule potentiators of metabotropic glutamate receptors

BRAJE WILFRIED2 citations51

POHLKI FRAUKE

2 patents
US8877794B2Nov 4, 2014

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

POHLKI FRAUKE1 citations50
US9045459B2Jun 2, 2015

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

POHLKI FRAUKE0 citations40

LANGE UDO

1 patent
US8642587B2Feb 4, 2014

Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy

LANGE UDO62 citations94

OCHSE MICHAEL

1 patent
US8653100B2Feb 18, 2014

Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy

OCHSE MICHAEL17 citations80

GENESTE HERVE

1 patent
US9242933B2Jan 26, 2016

Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)

GENESTE HERVE3 citations71

ABBVIE INC

1 patent
US10556907B2Feb 11, 2020

Fused heterocyclic compounds as S1P modulators

ABBVIE INC5 citations68

ABBOTT GMBH & CO KG

1 patent
US7790727B2Sep 7, 2010

Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

ABBOTT GMBH & CO KG4 citations60

BAYER AG

1 patent
US6794149B1Sep 21, 2004

GABA B receptors

BAYER AG1 citations51

ABBOTT LAB

1 patent
US7906120B2Mar 15, 2011

Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR)

ABBOTT LAB0 citations49

SCHULTZ THOMAS

1 patent
US8507469B2Aug 13, 2013

Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

SCHULTZ THOMAS2 citations45